Reduced plasminogen binding and delayed activation render γ′-fibrin more resistant to lysis than γa-fibrin

Journal of Biological Chemistry

Volumn 289, Issue 40, 2014, Pages 27494-27503

  Kim, Paul Y ^a,b   Vu, Trang T ^a,b   Leslie, Beverly A ^a,b   Stafford, Alan R ^a,b   Fredenburgh, James C ^a,b   Weitz, Jeffrey I ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RATE CONSTANTS;

ACTIVATION KINETICS; ASSOCIATION RATE CONSTANTS; DELAYED ACTIVATION; ISOFORMS; LAG-TIME; TISSUE PLASMINOGEN ACTIVATOR (TPA); UPPER LIMITS;

CHEMICAL ACTIVATION;

BATROXOBIN; BLOOD CLOTTING FACTOR 13A; FIBRIN; FIBRINOPEPTIDE B; GAMMA A FIBRIN; GAMMA' FIBRIN; PLASMIN; PLASMINOGEN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; FIBRINOGEN; PROTEIN BINDING;

ARTICLE; FIBRIN CLOT; FIBRINOLYSIS; KINETICS; LYSIS; PLASMINOGEN ACTIVATION; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; PROTEIN ISOLATION; PROTEIN SECRETION; BLOOD CLOTTING; CHEMISTRY; HUMAN; METABOLISM;

BLOOD COAGULATION; FIBRIN; FIBRINOGEN; FIBRINOLYSIN; FIBRINOLYSIS; FIBRINOPEPTIDE B; HUMANS; KINETICS; PLASMINOGEN; PROTEIN BINDING; THROMBIN;

EID: 84907484275     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.588640     Document Type: Article

References (41)

1. Walker, J. B., and Nesheim, M. E. (1999) The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J. Biol. Chem. 274, 5201-5212
2. Mosesson, M. W. (2005) Fibrinogen and fibrin structure and functions. J. Thromh. Haemost. 3, 1894-904
3. Fredenburgh, J. C., Stafford, A. R., Leslie, B. A., and Weitz, J. I. (2008) Bivalent binding to γA/γ′-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. J. Biol. Chem. 283, 2470-2477
4. Pospisil, C. H., Stafford, A. R., Fredenburgh, J. C., and Weitz, J. I. (2003) Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin. J. Biol. Chem. 278, 21584-21591
5. Suenson, E., Bjerrum, P., Holm, A., Lind, B., Meldal, M., Selmer, J., and Petersen, L. C. (1990) The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation. J. Biol. Chem. 265, 22228-22237
6. Cooper, A. V., Standeven, K. F., and Ariëns, R. A. (2003) Fibrinogen γ-chain splice variant γ′ alters fibrin formation and structure. Blood 102, 535-540
7. Wolberg, A. S. (2012) Determinants of fibrin formation, structure, and function. Curr. Opin. Hematol. 19, 349-356
8. Meh, D. A., Siebenlist, K. R., and Mosesson, M. W. (1996) Identification and characterization of the thrombin binding sites on fibrin. J. Biol. Chem. 271, 23121-23125
9. Chan, H. H., Leslie, B. A., Stafford, A. R., Roberts, R. S., Al-Aswad, N. N., Fredenburgh, J. C., and Weitz, J. I. (2012) By increasing the affinity of heparin for fibrin, Zn2+ promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by anti-thrombin. Biochemistry 51, 7964-7973
10. Allan, P., Uitte de Willige, S., Abou-Saleh, R. H., Connell, S. D., and Ariëns, R. A. (2012) Evidence that fibrinogen γ′ directly interferes with protofibril growth: implications for fibrin structure and clot stiffness J. Thromb. Haemost. 10, 1072-1080
11. Gersh, K. C., Nagaswami, C., Weisel, J. W., and Lord, S. T. (2009) The presence of γ′ chain impairs fibrin polymerization. Thromb. Res. 124, 356 -363
12. Horrevoets, A. J., Pannekoek, H., and Nesheim, M. E. (1997) A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain. J. Biol. Chem. 272, 2183-2191
13. Kim, P. Y., Tieu, L. D., Stafford, A. R., Fredenburgh,J. C., and Weitz, J. I. (2012) A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator. J. Biol. Chem. 287, 4652-4661
14. Tsurupa, G., and Medved, L. (2001) Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) α C-domains. Biochemistry 40, 801-808
15. Doolittle, R. F., and Pandi, L. (2006) Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Biochemistry 45, 2657-2667
16. Falls, L. A., and Farrell, D. H. (1997) Resistance of γA/γ fibrin clots to fibrinolysis. J. Biol. Chem. 272, 14251-14256
17. Collet, J. P., Nagaswami, C., Farrell, D. H., Montalescot, G., and Weisel, J. W. (2004) Influence of γ′ fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler. Thromb. Vase. Biol. 24, 382-386
18. Castellino, F. J., and Powell, J. R. (1981) Human plasminogen. Methods Enzymol. 80, 365-378
19. Stewart, R.J., Fredenburgh,J. C., and Weitz, J.I. (1998) Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E. J. Biol. Chem. 273, 18292-18299
20. Horrevoets, A. J.G., Pannekoek, H., and Nesheim, M.E. (1997) Production and characterization of recombinant human plasminogen (S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease. J. Biol. Chem. 272, 2176-2182
21. Siebenlist, K. R., Meh, D. A., and Mosesson, M. W. (1996) Plasma factor XIII binds specifically to fibrinogen molecules containing γ′ chains. Biochemistry 35, 10448 -10453
22. Vu, T. T., Stafford, A. R., Leslie, B. A., Kim, P. Y., Fredenburgh,J. C., and Weitz, J. I. (2013) Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin. J. Biol. Chem. 288, 16862-16871
23. Kim, P. Y., Stewart, R.J., Lipson, S. M., and Nesheim, M. E. (2007) The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease. J. Thromb. Haemost. 5, 1250-1256
24. Schneider, M., and Nesheim, M. (2004) A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis. J. Biol. Chem. 279, 13333-13339
25. Vu, T. T., Stafford, A. R., Leslie, B. A., Kim, P. Y., Fredenburgh, J. C., and Weitz, J. I. (2011) Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the γ′-chain. J. Biol. Chem. 286, 30314-30323
26. Ye, J., Rezaie, A. R., and Esmon, C. T. (1994) Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101. J. Biol. Chem. 269, 17965-17970
27. Senis, Y. A., Kim, P. Y., Fuller, G. L., García, A., Prabhakar, S., Wilkinson, M. C., Brittan, H., Zitzmann, N., Wait, R., Warrell, D. A., Watson, S. P., Kamiguti, A. S., Theakston, R. D., Nesheim, M. E., and Laing, G. D. (2006) Isolation and characterization of cotiaractivase, a novel low molecular weight prothrombin activator from the venom of Bothrops cotiara. Biochim. Biophys. Acta 1764, 863-871
28. Dejouvencel, T., Doeuvre, L., Lacroix, R., Plawinski, L., Dignat-George, F., Lijnen, H. R., and Anglés-Cano, E. (2010) Fibrinolytic cross-talk: a new mechanism for plasmin formation. Blood 115, 2048-2056
29. Ariëns, R. A., Lai, T. S., Weisel, J. W., Greenberg, C. S., and Grant, P.J. (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100, 743-754
30. Hethershaw, E. L., Cilia La Corte, A. L., Duval, C., Ali, M., Grant, P. J., Ariëns, R. A., and Philippou, H. (2014) The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis. J. Thromb. Haemost. 12, 197-205
31. Hoylaerts, M., Rijken, D. C., Lijnen, H. R., and Collen, D. (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J. Biol. Chem. 257, 2912-2919
32. Maresca, G., Di Blasio, A., Marchioli, R., and Di Minno, G. (1999) Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler. Thromb. Vase. Biol. 19, 1368-1377
33. Tribouilloy, C., Peltier, M., Colas, L., Senni, M., Ganry, O., Rey, J. L., and Lesbre, J. P. (1998) Fibrinogen is an independent marker for thoracic aortic atherosclerosis. Am. J. Cardiol. 81, 321-326
34. Danesh, J., Collins, R., Appleby, P., and Peto, R. (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279, 1477-1482
35. Ma, J., Hennekens, C. H., Ridker, P. M., and Stampfer, M. J. (1999) A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study. J. Am. Coll. Cardiol. 33, 1347-1352
36. Cheung, E. Y., Uitte de Willige, S., Vos, H. L., Leebeek, F. W., Dippel, D. W., Bertina, R. M., and de Maat, M. P. (2008) Fibrinogen γ′ in ischemic stroke: a case-control study. Stroke 39, 1033-1035
37. Pieters, M., Kotze, R. C., Jerling,J. C., Kruger, A., and Ariëns, R. A. (2013) Evidence that fibrinogen γ′ regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans. Blood 121, 3254-3260
38. Uitte de Willige, S., de Visser, M. C., Houwing-Duistermaat, J. J., Rosendaal, F. R., Vos, H. L., and Bertina, R. M. (2005) Genetic variation in the fibrinogen γ gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen γ′ levels. Blood 106, 4176-4183
39. Mannila, M. N., Lovely, R. S., Kazmierezak, S. C., Eriksson, P., Samnegård, A., Farrell, D. H., Hamsten, A., and Silveira, A. (2007) Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. J. Thromb. Haemost. 5, 766-773
40. Lovely, R. S., Kazmierczak, S. C., Massaro, J. M., D'Agostino, R. B., Sr., O'Donnell, C. J., and Farrell, D. H. (2010) γ′ fibrinogen: evaluation of anew assay for study of associations with cardiovascular disease. Clin. Chem. 56, 781-788
41. Lovely, R. S., Falls, L. A., Al-Mondhiry, H. A., Chambers, C. E., Sexton, G. J., Ni, H., and Farrell, D. H. (2002) Association of γA/γ′ fibrinogen levels and coronary artery disease. Thromb. Haemost. 88, 26-31